Alan announces a €480 million financing round to make prevention insurance the new global standard in healthcare
Alan, a company focused on transforming healthcare through prevention, technology, and artificial intelligence, has announced a Series G financing round of €480 million (approximately $550 million). This round values the company at €5.5 billion ($6.3 billion) and is led by Prosus, a major global technology investor from the Netherlands. Existing shareholders, including Teachers' Venture Growth and Index Ventures, along with new investors Dara Holdings, also participated. The financing's closure will depend on regulatory approvals from relevant French financial authorities.
This funding represents a significant milestone for Alan, which aims to shift healthcare's emphasis from treating illnesses to prioritizing prevention and long-term health outcomes. The company intends to leverage artificial intelligence to accelerate this transition.
Over the last decade, Alan has evolved from a traditional health insurer to a pioneer in the prevention insurance sector. The company seeks to disrupt the current healthcare model, which often requires patients to wait for symptoms to worsen before taking action. Alan's integrated approach combines health coverage, care navigation, and AI-powered assistance, allowing members to proactively manage their health.
With this new round of financing, Alan plans to expand its model into new international markets, strengthen its presence in existing ones like France, Belgium, Spain, and Canada, pursue acquisitions, and invest further in artificial intelligence and healthcare innovations.
By Q1 2026, Alan achieved over €800 million in Annual Recurring Revenue, marking a 53% year-over-year growth and surpassing 1.1 million members while maintaining profitability in France.
CEO Jean-Charles Samuelian-Werve emphasized the need for timely healthcare interventions and the company's commitment to making prevention a universal right. Fahd Beg, Head of Investments at Prosus, noted that Alan's integrated platform creates an exceptional healthcare experience, reinforcing the significance of their partnership in accelerating international expansion.